BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Spearman CW, Aghemo A, Valenti L, Sonderup MW. COVID-19 and the liver: A 2021 update. Liver Int 2021;41:1988-98. [PMID: 34152690 DOI: 10.1111/liv.14984] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Valenti L, Ronzoni L. Genetics: A new clinical tool for the hepatologist. Liver Int 2022;42:724-6. [PMID: 35289075 DOI: 10.1111/liv.15205] [Reference Citation Analysis]
2 Aloisio E, Panteghini M. Aspartate aminotransferase in COVID-19: A probably overrated marker. Liver Int 2021;41:2809-10. [PMID: 34609789 DOI: 10.1111/liv.15068] [Reference Citation Analysis]
3 Bakasis A, Bitzogli K, Mouziouras D, Pouliakis A, Roumpoutsou M, Goules AV, Androutsakos T. Antibody Responses after SARS-CoV-2 Vaccination in Patients with Liver Diseases. Viruses 2022;14:207. [DOI: 10.3390/v14020207] [Reference Citation Analysis]
4 Desai AD, Lavelle M, Boursiquot BC, Wan EY. Long-term complications of COVID-19. Am J Physiol Cell Physiol 2022;322:C1-C11. [PMID: 34817268 DOI: 10.1152/ajpcell.00375.2021] [Reference Citation Analysis]
5 Luo K, Chen Y, Yang J, Tao Q, Luo M. Liver Injury and Elevated Levels of Interleukins, Interleukin-2 Receptor, and Interleukin-6 Predict the Severity in Patients With COVID-19. Front Public Health 2021;9:778340. [PMID: 34970527 DOI: 10.3389/fpubh.2021.778340] [Reference Citation Analysis]